azathioprine has been researched along with Liver Cirrhosis, Biliary in 109 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Liver Cirrhosis, Biliary: FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "sICAM-1 levels in primary biliary cirrhosis are reduced by ursodeoxycholic acid." | 9.08 | Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy. ( Jazrawi, RP; Levy, JH; Lim, AG; Northfield, TC; Schalm, SW; van Buuren, HR; Verma, A; Wolfhagen, FH, 1997) |
| "A 1-year randomized, double-blind, placebo-controlled trial was carried out in 50 patients with primary biliary cirrhosis, who had already been treated with ursodeoxycholic acid for at least 1 year, but had not achieved complete disease remission." | 9.08 | Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study. ( de Vries, RA; den Ouden, JW; Hop, WC; Kerbert, MJ; Schalm, SW; Smit, AM; ten Kate, FJ; van Berge-Henegouwen, GP; van Buuren, HR; van der Hoek, EW; van Hoogstraten, HJ; van Lijf, HH; van Zanten, RA; Wolfhagen, FH, 1998) |
| "The effects of azathioprine on the course of primary biliary cirrhosis were studied prospectively in a multinational, double-blind randomized clinical trial involving 236 patients, of which 124 received azathioprine and 112 placebo." | 9.05 | Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. ( Christensen, E; Cochrane, M; Crowe, J; Doniach, D; Popper, H; Ranek, L; Smith, M; Tygstrup, N; Watkinson, G; Williams, R, 1980) |
| "The effect of azathioprine on survival of patients with primary biliary cirrhosis was studied prospectively in a multinational, double-blind, randomized clinical trial including 248 patients of whom 127 received azathioprine and 121 placebo." | 9.05 | Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. ( Altman, DG; Christensen, E; Crowe, J; Doniach, D; Neuberger, J; Popper, H; Portmann, B; Ranek, L; Tygstrup, N; Williams, R, 1985) |
| "Azathioprine is used for patients with primary biliary cirrhosis, but the therapeutic responses in randomised clinical trials have been conflicting." | 8.84 | Azathioprine for primary biliary cirrhosis. ( Christensen, E; Gluud, C; Gong, Y, 2007) |
| " Some histopathological features consistent with azathioprine hepatotoxicity like cholestasis, perisinusoidal fibrosis, veno-subocclusive lesions and nodular regenerative hyperplasia were also observed in this case." | 7.70 | Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor? ( Aguado, JM; Colina, F; Delgado, J; Fuertes, A; Gomez, MA; Ibarrola, C; Morales, JM; Muñoz de Bustillo, E; Rodriguez, E, 1999) |
| "A 36-yr-old woman with primary biliary cirrhosis developed a Goodpasture's-like syndrome while on D-penicillamine treatment." | 7.66 | D-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis--successful treatment with plasmapheresis and immunosuppressives. ( Kaplan, MM; Matloff, DS, 1980) |
| " We analyzed their biochemistries, immune parameters, liver synthetic function, and noninvasive assessments of liver fibrosis, as well as treatment efficacy and adverse effects at baseline and at 1, 3, 6, 12, 24, and 36 months." | 5.40 | Case-control study on prednisolone combined with ursodeoxycholic acid and azathioprine in pure primary biliary cirrhosis with high levels of immunoglobulin G and transaminases: efficacy and safety analysis. ( Deng, YQ; Fang, YQ; Jia, W; Li, J; Lv, DX; Wang, GQ; Wang, Y; Yu, M, 2014) |
| "A 1-year randomized, double-blind, placebo-controlled trial was carried out in 50 patients with primary biliary cirrhosis, who had already been treated with ursodeoxycholic acid for at least 1 year, but had not achieved complete disease remission." | 5.08 | Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study. ( de Vries, RA; den Ouden, JW; Hop, WC; Kerbert, MJ; Schalm, SW; Smit, AM; ten Kate, FJ; van Berge-Henegouwen, GP; van Buuren, HR; van der Hoek, EW; van Hoogstraten, HJ; van Lijf, HH; van Zanten, RA; Wolfhagen, FH, 1998) |
| "sICAM-1 levels in primary biliary cirrhosis are reduced by ursodeoxycholic acid." | 5.08 | Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy. ( Jazrawi, RP; Levy, JH; Lim, AG; Northfield, TC; Schalm, SW; van Buuren, HR; Verma, A; Wolfhagen, FH, 1997) |
| "We describe a bootstrap investigation of the stability of a Cox proportional hazards regression model resulting from the analysis of a clinical trial of azathioprine versus placebo in patients with primary biliary cirrhosis." | 5.06 | Bootstrap investigation of the stability of a Cox regression model. ( Altman, DG; Andersen, PK, 1989) |
| "The effects of azathioprine on the course of primary biliary cirrhosis were studied prospectively in a multinational, double-blind randomized clinical trial involving 236 patients, of which 124 received azathioprine and 112 placebo." | 5.05 | Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. ( Christensen, E; Cochrane, M; Crowe, J; Doniach, D; Popper, H; Ranek, L; Smith, M; Tygstrup, N; Watkinson, G; Williams, R, 1980) |
| "The effect of azathioprine on survival of patients with primary biliary cirrhosis was studied prospectively in a multinational, double-blind, randomized clinical trial including 248 patients of whom 127 received azathioprine and 121 placebo." | 5.05 | Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. ( Altman, DG; Christensen, E; Crowe, J; Doniach, D; Neuberger, J; Popper, H; Portmann, B; Ranek, L; Tygstrup, N; Williams, R, 1985) |
| "Azathioprine is used for patients with primary biliary cirrhosis, but the therapeutic responses in randomised clinical trials have been conflicting." | 4.84 | Azathioprine for primary biliary cirrhosis. ( Christensen, E; Gluud, C; Gong, Y, 2007) |
| "MODE OF ACTION OF URSODEOXYCHOLIC ACID: In cholestasis, the impaired biliary secretion of toxic bile acids causes their accumulation in the liver and a subsequent hepatic failure." | 4.81 | [Treatment of cholestatic liver diseases]. ( Gatzen, M; Pausch, J, 2002) |
| "Treatment of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) with ursodeoxycholic acid (UDCA) has been in common use since 1985." | 4.81 | Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. ( Holtmeier, J; Leuschner, U, 2001) |
| " For primary biliary cirrhosis, ursodeoxycholic acid is safe and is the first choice for treatment." | 3.74 | Guidelines for therapy of autoimmune liver disease. ( Gershwin, ME; Ishibashi, H; Komori, A; Shimoda, S, 2007) |
| " Some histopathological features consistent with azathioprine hepatotoxicity like cholestasis, perisinusoidal fibrosis, veno-subocclusive lesions and nodular regenerative hyperplasia were also observed in this case." | 3.70 | Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor? ( Aguado, JM; Colina, F; Delgado, J; Fuertes, A; Gomez, MA; Ibarrola, C; Morales, JM; Muñoz de Bustillo, E; Rodriguez, E, 1999) |
| "Serum squalene levels did not change in patients with acute hepatitis, chronic active hepatitis and liver cirrhosis, but were significantly reduced in patients with intra- and extrahepatic cholestasis." | 3.66 | Serum squalene levels in hepatobiliary diseases. ( Hirayama, C; Ikawa, S; Yamanishi, Y, 1978) |
| "A 36-yr-old woman with primary biliary cirrhosis developed a Goodpasture's-like syndrome while on D-penicillamine treatment." | 3.66 | D-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis--successful treatment with plasmapheresis and immunosuppressives. ( Kaplan, MM; Matloff, DS, 1980) |
| "De novo autoimmune hepatitis (AIH) is an unusual cause of graft dysfunction after liver transplantation." | 2.58 | De novo autoimmune hepatitis -is this different in adults compared to children? ( Kerkar, N; Vergani, D, 2018) |
| "Primary biliary cholangitis (PBC, primary biliary cirrhosis) is an autoimmune cholestatic liver disease characterized by chronic nonsuppurative destructive cholangitis and the presence of serum antimitochondrial antibodies." | 2.53 | Therapeutic advances for primary biliary cholangitis: the old and the new. ( Wang, L; Zhang, FC; Zhang, X, 2016) |
| "Unlike other autoimmune liver diseases, primary biliary cirrhosis (PBC) has never been reported in early childhood, while type 2 autoimmune hepatitis (AIH) is eminently a paediatric disease." | 2.48 | Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. ( Alessio, MG; Bogdanos, DP; Candusso, M; Fabris, L; Invernizzi, P; Iorio, R; Lleo, A; Smyk, DS; Sonzogni, A; Torre, G, 2012) |
| "Autoimmune Hepatitis (AIH), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC) and overlap syndromes of these three disease entities are regarded as autoimmune liver diseases." | 2.42 | [Autoimmune liver disease: diagnosis and therapy]. ( Bayer, EM; Kanzler, S; Lohse, AW; Schramm, C, 2004) |
| "The diagnosis and management of autoimmune hepatitis continues to evolve as new diagnostic tests and new therapies are added to the armamentarium." | 2.41 | Autoimmune liver disease. Current standards, future directions. ( Gish, RG; Mason, A, 2001) |
| "Autoimmune Hepatitis (AIH), primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) represent acute and chronic inflammatory liver diseases in which immune reactions against host antigens are found to be the major pathological mechanism." | 2.41 | [Autoimmune hepatitis and overlap syndrome: therapy]. ( Löhr, HF, 2002) |
| "Primary biliary cirrhosis (PBC) is a disease which predominantly affects middle-aged women and is characterized by destruction of the interlobular bile ducts by chronic, often granulomatous, inflammation." | 2.40 | Evidence-based therapy of primary biliary cirrhosis. ( Heathcote, EJ, 1999) |
| "For conservative therapy of primary biliary cirrhosis, D-penicillamine is contraindicated and several immunosuppressants investigated are associated with unacceptable side effects; ursodeoxycholic acid, colchicine and perhaps methotrexate seem to be promising, but none has been proven to prolong survival." | 2.39 | [Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis]. ( Renner, EL, 1994) |
| "Primary biliary cirrhosis is a disease where small intra-hepatic bile ducts are destroyed as a result of an immunological reaction, presumably by cytotoxic T-lymphocytes on biliary epithelium." | 2.36 | Primary biliary cirrhosis: critical evaluation and treatment policies. ( Sherlock, S, 1982) |
| "Patients with autoimmune hepatitis in Switzerland had clinical features similar to those in other cohorts." | 1.91 | Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study. ( Becker, B; Bernsmeier, C; Böhm, S; Braegger, C; Bresson-Hadni, S; Cerny, A; Cremer, M; De Gottardi, A; Di Bartolomeo, C; Filipowicz Sinnreich, M; Furlano, R; Galante, A; Heyland, K; Kremer, AE; Limoni, C; Ludz, C; McLin, V; Mertens, J; Mieli-Vergani, G; Müller, P; Nydegger, A; Posovszky, C; Righini-Grunder, F; Rock, N; Semela, D; Sokollik, C; Stirnimann, G; Terziroli Beretta-Piccoli, B; Vergani, D, 2023) |
| "Overlap syndrome is the combination of autoimmune liver diseases, and this term usually describes the coexistence of autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) in the same patient." | 1.91 | Coexistence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome and membranous nephropathy: A case report. ( Chen, H; Gao, X; Hong, X; Hu, S; Jin, X; Qiao, Z; Xia, C; Xiang, X; Xu, Y; Zhang, P, 2023) |
| "PCA associated with autoimmune hepatitis-primary biliary cirrhosis (AIH-PBC) overlap syndrome and Sjögren syndrome (SS) has not been previously reported in the literature." | 1.48 | Primary cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Sjögren syndrome: A case report. ( Jin, J; Yan, X, 2018) |
| " We analyzed their biochemistries, immune parameters, liver synthetic function, and noninvasive assessments of liver fibrosis, as well as treatment efficacy and adverse effects at baseline and at 1, 3, 6, 12, 24, and 36 months." | 1.40 | Case-control study on prednisolone combined with ursodeoxycholic acid and azathioprine in pure primary biliary cirrhosis with high levels of immunoglobulin G and transaminases: efficacy and safety analysis. ( Deng, YQ; Fang, YQ; Jia, W; Li, J; Lv, DX; Wang, GQ; Wang, Y; Yu, M, 2014) |
| "Treatment with prednisone and azathioprine resulted in a dramatically improved outcome." | 1.36 | De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report. ( Wang, B; Wang, T; Zhang, Y, 2010) |
| "Treatment with prednisone and azathioprine may lead to a rapid improvement in aminotransferase levels." | 1.34 | Development of autoimmune hepatitis in primary biliary cirrhosis. ( Gossard, AA; Lindor, KD, 2007) |
| "Life threatening cardiac arrhythmia was the first clinical manifestation of the disease." | 1.33 | [Overlap syndrome autoimmune hepatitis and primary biliary cirrhosis associated with antiphospholipid syndrome]. ( Laskowska, K; Majdan, M; Suszek, D; Targońska-Stepniak, B, 2006) |
| "Autoimmune hepatitis and primary biliary cirrhosis are two different liver diseases." | 1.32 | [The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases]. ( Ben Ammar, A; Chaabouni, H; Cheikh, I; Ouerghi, H; Said, Y, 2003) |
| "Autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) are two different liver diseases, however diagnosis criteria of these two affections can be found in a same patient." | 1.32 | [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients]. ( Ben Ammar, A; Chaabouni, H; Cheikh, I; Ouerghi, H; Said, Y, 2003) |
| "Bullous pemphigoid is the most frequent autoimmune blistering skin disease." | 1.31 | [Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?]. ( Géniaux, M; Marcet, B; Sibaud, V; Taieb, A, 2002) |
| "In primary biliary cirrhosis (PBC), liver damage results from both immune- and bile acid-mediated mechanisms." | 1.30 | Bile acid therapy and markers of immune-mediated damage in primary biliary cirrhosis. ( de Caestecker, JS, 1997) |
| " There was no increase in concurrent immunosuppressives dosage after the conversion." | 1.29 | Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation. ( Kaplan, MM; Pedrosa, MC; Rohrer, RM, 1995) |
| "A case of primary biliary cirrhosis (PBC) presenting as idiopathic thrombocytopenic purpura is described." | 1.28 | Primary biliary cirrhosis presenting as idiopathic thrombocytopenic purpura with deterioration after splenectomy. ( Hansson, G; Wallerstedt, S; Westin, J, 1989) |
| "Primary biliary cirrhosis is characterized by chronic inflammation and necrosis of the intrahepatic bile ducts and by chronic cholestasis." | 1.27 | NIH conference: Primary biliary cirrhosis: a model autoimmune disease. ( Hoofnagle, JH; James, SP; Jones, EA; Strober, W, 1983) |
| "Ten patients with primary biliary cirrhosis (PBC) were clinically followed under the conditions of follow-up care." | 1.27 | [Clinical-dispensary finding of patients with primary biliary cirrhosis]. ( Bakalov, V; Chernev, K, 1985) |
| "Treatment with prednisolone should be given for at least two years, with adjustment of dosage according to the serum levels of aspartate transaminase; maintenance does should be 8-12 mg a day." | 1.27 | Treatment of chronic active hepatitis and other liver diseases with corticosteroid agents. ( Mackay, IR, 1987) |
| "15 patients with primary biliary cirrhosis (PBC) and 109 patients with chronic aggressive hepatitis (CAH) have been followed." | 1.26 | [Combined form of chronic aggressive hepatitis primary biliary cirrhosis]. ( Cueni, B; Schmid, M; Zimmermann, K, 1977) |
| "The previously unreported occurrence of primary biliary cirrhosis with cold autoimmune hemolytic anemia is described." | 1.26 | Primary biliary cirrhosis and cold autoimmune hemolytic anemia: effect of partial plasma exchange. ( Berkman, EM; Kaplan, MM; Matloff, DS; Orlin, JB, 1980) |
| "Primary biliary cirrhosis in twin sisters is described." | 1.25 | Primary biliary cirrhosis in twin sisters. ( Chohan, MR, 1973) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 56 (51.38) | 18.7374 |
| 1990's | 18 (16.51) | 18.2507 |
| 2000's | 19 (17.43) | 29.6817 |
| 2010's | 13 (11.93) | 24.3611 |
| 2020's | 3 (2.75) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, X | 1 |
| Hu, S | 1 |
| Zhang, P | 1 |
| Gao, X | 1 |
| Qiao, Z | 1 |
| Xia, C | 1 |
| Xu, Y | 1 |
| Jin, X | 1 |
| Xiang, X | 1 |
| Chen, H | 1 |
| Ludz, C | 1 |
| Stirnimann, G | 1 |
| Semela, D | 1 |
| Mertens, J | 1 |
| Kremer, AE | 1 |
| Filipowicz Sinnreich, M | 1 |
| Sokollik, C | 1 |
| Bernsmeier, C | 1 |
| Bresson-Hadni, S | 1 |
| McLin, V | 1 |
| Rock, N | 1 |
| Braegger, C | 1 |
| Posovszky, C | 1 |
| Müller, P | 1 |
| Cremer, M | 1 |
| De Gottardi, A | 1 |
| Galante, A | 1 |
| Furlano, R | 1 |
| Righini-Grunder, F | 1 |
| Becker, B | 1 |
| Böhm, S | 1 |
| Heyland, K | 1 |
| Nydegger, A | 1 |
| Limoni, C | 1 |
| Vergani, D | 2 |
| Mieli-Vergani, G | 1 |
| Di Bartolomeo, C | 1 |
| Cerny, A | 1 |
| Terziroli Beretta-Piccoli, B | 1 |
| Yik, B | 1 |
| Shah, N | 1 |
| Yan, X | 1 |
| Jin, J | 1 |
| Kerkar, N | 1 |
| Di Giorgio, A | 1 |
| D'Adda, A | 1 |
| Marseglia, A | 1 |
| Sonzogni, A | 2 |
| Licini, L | 1 |
| Nicastro, E | 1 |
| D'Antiga, L | 1 |
| Sisman, G | 1 |
| Erzin, Y | 1 |
| Bal, K | 1 |
| Fang, YQ | 1 |
| Lv, DX | 1 |
| Jia, W | 1 |
| Li, J | 1 |
| Deng, YQ | 1 |
| Wang, Y | 1 |
| Yu, M | 1 |
| Wang, GQ | 1 |
| Zhu, GQ | 1 |
| Huang, S | 1 |
| Huang, GQ | 1 |
| Wang, LR | 1 |
| Lin, YQ | 1 |
| Wu, YM | 1 |
| Shi, KQ | 1 |
| Wang, JT | 1 |
| Zhou, ZR | 1 |
| Braddock, M | 1 |
| Chen, YP | 1 |
| Zhou, MT | 1 |
| Zheng, MH | 1 |
| Wang, L | 2 |
| Zhang, FC | 2 |
| Zhang, X | 2 |
| Krok, KL | 1 |
| Munoz, SJ | 1 |
| Zhang, Y | 1 |
| Wang, B | 1 |
| Wang, T | 1 |
| Efe, C | 1 |
| Purnak, T | 1 |
| Ozaslan, E | 1 |
| Ozbalkan, Z | 1 |
| Karaaslan, Y | 1 |
| Altiparmak, E | 1 |
| Muratori, P | 2 |
| Wahlin, S | 1 |
| Invernizzi, P | 1 |
| Alessio, MG | 1 |
| Smyk, DS | 1 |
| Lleo, A | 1 |
| Fabris, L | 1 |
| Candusso, M | 1 |
| Bogdanos, DP | 1 |
| Iorio, R | 1 |
| Torre, G | 1 |
| Serghini, M | 1 |
| Haddad, W | 1 |
| Karoui, S | 1 |
| Ben Mustapha, N | 1 |
| Kallel, L | 1 |
| Fekih, M | 1 |
| Boubaker, J | 1 |
| Filali, A | 1 |
| Wang, Q | 1 |
| Selmi, C | 1 |
| Zhou, X | 1 |
| Qiu, D | 1 |
| Li, Z | 1 |
| Miao, Q | 1 |
| Chen, X | 1 |
| Wang, J | 1 |
| Krawitt, EL | 1 |
| Gershwin, ME | 2 |
| Han, Y | 1 |
| Ma, X | 1 |
| Gao, LX | 1 |
| Liu, B | 1 |
| Löhr, HF | 1 |
| Marcet, B | 1 |
| Sibaud, V | 1 |
| Géniaux, M | 1 |
| Taieb, A | 1 |
| Corpechot, C | 1 |
| Cheikh, I | 2 |
| Said, Y | 2 |
| Chaabouni, H | 2 |
| Ouerghi, H | 2 |
| Ben Ammar, A | 2 |
| Bayer, EM | 1 |
| Schramm, C | 1 |
| Kanzler, S | 1 |
| Lohse, AW | 1 |
| Czaja, AJ | 1 |
| Muratori, L | 1 |
| Carpenter, HA | 1 |
| Bianchi, FB | 1 |
| Royston, P | 1 |
| Altman, DG | 7 |
| Sauerbrei, W | 1 |
| Maier, KP | 1 |
| Strassburg, CP | 1 |
| Targońska-Stepniak, B | 1 |
| Majdan, M | 1 |
| Suszek, D | 1 |
| Laskowska, K | 1 |
| Ishibashi, H | 1 |
| Komori, A | 1 |
| Shimoda, S | 1 |
| Gong, Y | 1 |
| Christensen, E | 6 |
| Gluud, C | 1 |
| Gossard, AA | 1 |
| Lindor, KD | 1 |
| Paumgartner, G | 1 |
| Kolts, BE | 1 |
| Spindel, E | 1 |
| James, SP | 1 |
| Hoofnagle, JH | 1 |
| Strober, W | 1 |
| Jones, EA | 2 |
| Rull, S | 1 |
| Rodríguez-San Román, JL | 1 |
| Velilla, JP | 1 |
| Sherlock, S | 6 |
| Tittor, W | 1 |
| Crowe, J | 3 |
| Smith, M | 1 |
| Cochrane, M | 1 |
| Ranek, L | 4 |
| Watkinson, G | 2 |
| Doniach, D | 3 |
| Popper, H | 3 |
| Tygstrup, N | 5 |
| Williams, R | 7 |
| Mills, PR | 1 |
| Boyle, P | 1 |
| Quigley, EM | 1 |
| Birnie, GG | 1 |
| Jarrett, F | 1 |
| MacSween, RN | 1 |
| Volmer, J | 1 |
| Orlin, JB | 1 |
| Berkman, EM | 1 |
| Matloff, DS | 2 |
| Kaplan, MM | 6 |
| Pedrosa, MC | 1 |
| Rohrer, RM | 1 |
| Rifflet, H | 1 |
| Calés, P | 1 |
| Oberti, F | 1 |
| Fouchard, I | 1 |
| Rousselet, MC | 1 |
| Cottereau, J | 1 |
| Deugnier, Y | 1 |
| Dubin, J | 1 |
| Masson, C | 1 |
| Horsmans, Y | 1 |
| Piret, A | 1 |
| Brenard, R | 1 |
| Rahier, J | 1 |
| Geubel, AP | 2 |
| Renner, EL | 1 |
| De Stavola, BL | 2 |
| Neuberger, J | 3 |
| Taylor, SL | 1 |
| Dean, PJ | 1 |
| Riely, CA | 1 |
| Sánchez-Pobre, P | 1 |
| Castellano, G | 2 |
| Colina, F | 2 |
| Dominguez, P | 1 |
| Rodriguez, S | 1 |
| Canga, F | 1 |
| Herruzo, JA | 1 |
| de Caestecker, JS | 1 |
| Lim, AG | 1 |
| Wolfhagen, FH | 2 |
| Verma, A | 1 |
| van Buuren, HR | 2 |
| Jazrawi, RP | 1 |
| Levy, JH | 1 |
| Northfield, TC | 1 |
| Schalm, SW | 3 |
| Yela, C | 1 |
| Manzano, L | 1 |
| Garfia, C | 1 |
| Solis, JA | 1 |
| Elling, SV | 1 |
| Murphy, GM | 1 |
| Strobel, ES | 1 |
| Bonnet, RB | 1 |
| Werner, P | 1 |
| Schaefer, HE | 1 |
| Peter, HH | 1 |
| van Hoogstraten, HJ | 1 |
| van Berge-Henegouwen, GP | 1 |
| ten Kate, FJ | 1 |
| Hop, WC | 1 |
| van der Hoek, EW | 1 |
| Kerbert, MJ | 1 |
| van Lijf, HH | 1 |
| den Ouden, JW | 1 |
| Smit, AM | 1 |
| de Vries, RA | 1 |
| van Zanten, RA | 1 |
| Goto, T | 1 |
| Komatsu, M | 1 |
| Fujii, T | 1 |
| Ohshima, S | 1 |
| Nakane, K | 1 |
| Yoneyama, K | 1 |
| Shibuya, T | 1 |
| Meng, XW | 1 |
| Masamune, O | 1 |
| Imai, H | 1 |
| Delgado, J | 1 |
| Muñoz de Bustillo, E | 1 |
| Ibarrola, C | 1 |
| Morales, JM | 1 |
| Rodriguez, E | 1 |
| Aguado, JM | 1 |
| Fuertes, A | 1 |
| Gomez, MA | 1 |
| Heathcote, EJ | 1 |
| Gish, RG | 1 |
| Mason, A | 1 |
| Holtmeier, J | 1 |
| Leuschner, U | 1 |
| Lytton, SD | 1 |
| Berg, U | 1 |
| Nemeth, A | 1 |
| Ingelman-Sundberg, M | 1 |
| Gatzen, M | 1 |
| Pausch, J | 1 |
| Powell, LW | 1 |
| Tolman, KG | 1 |
| Ahmed, N | 1 |
| DeCoux, R | 1 |
| Thompson, FA | 1 |
| Achord, JL | 1 |
| van Berge Henegouwen, GP | 1 |
| Brandt, KH | 2 |
| Yamanishi, Y | 1 |
| Ikawa, S | 1 |
| Hirayama, C | 1 |
| Heathcote, J | 1 |
| Ross, A | 2 |
| Viteri, A | 1 |
| Vernace, SJ | 1 |
| Schaffner, F | 1 |
| Zimmermann, K | 1 |
| Cueni, B | 1 |
| Schmid, M | 1 |
| Baggenstoss, AH | 2 |
| Summerskill, WH | 3 |
| Brunner, G | 1 |
| Bray, GP | 1 |
| Andersen, PK | 1 |
| Wallerstedt, S | 1 |
| Westin, J | 1 |
| Hansson, G | 1 |
| Chernev, K | 1 |
| Bakalov, V | 1 |
| Royston, JP | 1 |
| Portmann, B | 2 |
| Adams, D | 1 |
| Clements, D | 1 |
| Elias, E | 1 |
| Mörl, M | 1 |
| Mackay, IR | 1 |
| Roll, J | 1 |
| Warnes, TW | 1 |
| Schiödt, T | 1 |
| Söborg, M | 1 |
| Pagaltsos, AP | 1 |
| Smith, MG | 2 |
| Eddleston, AL | 2 |
| Fung, WP | 1 |
| Hofstetter, JR | 1 |
| Realini, S | 1 |
| Fontolliet, CH | 1 |
| Gardiol, D | 1 |
| Klatskin, G | 1 |
| Kantor, FS | 1 |
| Lesesne, HR | 1 |
| Fallon, HJ | 1 |
| Whelan, G | 1 |
| Soloway, RD | 2 |
| Chohan, MR | 1 |
| Maleev, A | 1 |
| Stojanov, S | 1 |
| Golding, PL | 1 |
| Mitchell, CG | 1 |
| Kemp, A | 1 |
| Elveback, LR | 1 |
| Schoenfield, LJ | 1 |
| Lampe, K | 1 |
| Hüdepohl, M | 1 |
| Schopen, RD | 1 |
| Bronkhorst, FB | 1 |
| Magyar, I | 1 |
| Mistilis, SP | 1 |
32 reviews available for azathioprine and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Autoconversion of Autoimmune Liver Diseases.
Topics: Adult; Autoantibodies; Autoimmunity; Azathioprine; Biomarkers; Cholagogues and Choleretics; Diagnost | 2020 |
De novo autoimmune hepatitis -is this different in adults compared to children?
Topics: Adult; Age Factors; Autoantibodies; Azathioprine; Child; Female; Graft Rejection; Hepatitis C; Hepat | 2018 |
Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Bezafibrate; Bile Ducts; Colchicine; Cyclosporin | 2015 |
Therapeutic advances for primary biliary cholangitis: the old and the new.
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chenodeoxycholic Acid; Cholagogues | 2016 |
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature.
Topics: Antibodies, Anti-Idiotypic; Azathioprine; Child, Preschool; Female; Glucocorticoids; Hepatitis, Auto | 2012 |
[Autoimmune hepatitis and overlap syndrome: therapy].
Topics: Azathioprine; Cholangitis, Sclerosing; Drug Therapy, Combination; Haplotypes; Hepatitis, Autoimmune; | 2002 |
[Primary biliary cirrhosis].
Topics: Anti-Inflammatory Agents; Azathioprine; Biopsy, Needle; Cholagogues and Choleretics; Female; Gastros | 2003 |
[Autoimmune liver disease: diagnosis and therapy].
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Biopsy; Child; Cholagogues and Choleretics | 2004 |
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Scleros | 2005 |
[Autoimmune liver diseases and their overlap syndromes].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Azath | 2006 |
Azathioprine for primary biliary cirrhosis.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Quality of Life; Randomize | 2007 |
[Therapy of liver cirrhosis].
Topics: Adrenal Cortex Hormones; Azathioprine; Chronic Disease; Colchicine; Hepatitis; Humans; Liver Cirrhos | 1983 |
Chronic active hepatitis.
Topics: alpha 1-Antitrypsin Deficiency; Autoimmune Diseases; Azathioprine; Diagnosis, Differential; Drug The | 1984 |
[Current aspects of primary biliary cirrhosis (2)].
Topics: Azathioprine; Biliary Tract Diseases; Cholestyramine Resin; Cyclosporins; Diagnosis, Differential; H | 1983 |
Primary biliary cirrhosis: critical evaluation and treatment policies.
Topics: Adrenal Cortex Hormones; Adult; Antibodies; Azathioprine; Copper; Female; Humans; Liver; Liver Cirrh | 1982 |
Primary biliary cirrhosis: a challenging disease for hepatologists and immunologists.
Topics: Azathioprine; Chlorambucil; Cholestyramine Resin; Copper; Cyclophosphamide; Female; Humans; Liver; L | 1981 |
Treatment and prognosis of primary biliary cirrhosis.
Topics: Antigen-Antibody Complex; Azathioprine; Collagen; Copper; Cyclosporins; Humans; Liver; Liver Cirrhos | 1981 |
[Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis].
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Hepatitis, Chronic; Humans; Immunosuppre | 1994 |
Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates.
Topics: Aged; Analysis of Variance; Azathioprine; Clinical Trials as Topic; Double-Blind Method; Female; Fol | 1994 |
Evidence-based therapy of primary biliary cirrhosis.
Topics: Azathioprine; Bile Acids and Salts; Chlorambucil; Colchicine; Cyclosporine; Drug Therapy, Combinatio | 1999 |
Autoimmune liver disease. Current standards, future directions.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Cholagogues and Choleretics; Cholangiti | 2001 |
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Topics: Azathioprine; Celiac Disease; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Co | 2001 |
[Treatment of cholestatic liver diseases].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bile; Child; Cholagogues and Choleretics | 2002 |
Treatment of inflammatory and metal storage diseases of the liver.
Topics: Adrenal Cortex Hormones; Azathioprine; Bloodletting; Chelating Agents; Chronic Disease; Copper; Fema | 1979 |
Immunointervention in primary biliary cirrhosis: an overview.
Topics: Adrenal Cortex Hormones; Azathioprine; Chlorambucil; Cyclosporine; Humans; Immunosuppressive Agents; | 1992 |
Prognostication in primary biliary cirrhosis: relevance to the individual patient.
Topics: Azathioprine; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Models, Theoretical; Penicill | 1989 |
The treatment of primary biliary cirrhosis.
Topics: Adrenal Cortex Hormones; Antipruritics; Azathioprine; Celiac Disease; Chlorambucil; Colchicine; Cycl | 1986 |
Primary biliary cirrhosis.
Topics: Azathioprine; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Penicillamine | 1987 |
Treatment of primary biliary cirrhosis.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Chlorambucil; Cholelithiasis; Colchicine | 1985 |
Cytotoxic drugs in treatment of nonmalignant diseases.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlor | 1972 |
Treatment of liver disease with corticosteroids.
Topics: Adrenal Cortex Hormones; Alcoholism; Azathioprine; Chemical and Drug Induced Liver Injury; Glucocort | 1973 |
Chronic hepatitis.
Topics: Adult; Animals; Autoimmune Diseases; Azathioprine; Chemical and Drug Induced Liver Injury; Child; Ch | 1974 |
16 trials available for azathioprine and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
[The clinical observation of different therapeutic strategies in combined primary biliary cirrhosis and Sjögren syndrome].
Topics: Adult; Azathioprine; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prednisolone; Sjog | 2012 |
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Azathioprine; Bile Ducts; Cell Nucleus; Cholangitis; | 2004 |
Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial.
Topics: Actuarial Analysis; Age Factors; Azathioprine; Clinical Trials as Topic; Double-Blind Method; Ethnic | 1980 |
Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates.
Topics: Aged; Analysis of Variance; Azathioprine; Clinical Trials as Topic; Double-Blind Method; Female; Fol | 1994 |
Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups.
Topics: Azathioprine; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Models, Statistical; Probabil | 1993 |
Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy.
Topics: Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Cholagogues a | 1997 |
Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study.
Topics: Adult; Anti-Inflammatory Agents; Autoimmunity; Azathioprine; Cholagogues and Choleretics; Double-Bli | 1998 |
A prospective controlled trial of azathioprine in primary biliary cirrhosis.
Topics: Azathioprine; Clinical Trials as Topic; Female; Humans; Immunoglobulin M; Liver; Liver Cirrhosis, Bi | 1976 |
Bootstrap investigation of the stability of a Cox regression model.
Topics: Azathioprine; Clinical Trials as Topic; Double-Blind Method; Humans; Liver Cirrhosis, Biliary; Model | 1989 |
The hidden effect of time.
Topics: Aged; Azathioprine; Bilirubin; Blood Pressure Determination; Circadian Rhythm; Clinical Trials as To | 1988 |
Azathioprine and prognosis in primary biliary cirrhosis.
Topics: Azathioprine; Clinical Trials as Topic; Humans; Liver Cirrhosis, Biliary | 1986 |
Another treatment for primary biliary cirrhosis.
Topics: Azathioprine; Chlorambucil; Colchicine; Humans; Liver Cirrhosis, Biliary | 1987 |
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial.
Topics: Actuarial Analysis; Adult; Aged; Azathioprine; Clinical Trials as Topic; Double-Blind Method; Female | 1985 |
A new treatment for primary biliary cirrhosis?
Topics: Aged; Azathioprine; Clinical Trials as Topic; Humans; Liver Cirrhosis, Biliary; Liver Transplantatio | 1985 |
A trial of azathiorrine in primary biliary cirrhosis.
Topics: Azathioprine; Clinical Trials as Topic; Humans; Immunoglobulins; Liver Cirrhosis, Biliary | 1970 |
Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution.
Topics: Acute Disease; Adolescent; Adult; Aged; Autopsy; Azathioprine; Biopsy; Cholangitis; Chronic Disease; | 1972 |
62 other studies available for azathioprine and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Coexistence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome and membranous nephropathy: A case report.
Topics: Azathioprine; Glomerulonephritis, Membranous; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliar | 2023 |
Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
Topics: Adolescent; Adult; Azathioprine; Budesonide; Child; Child, Preschool; Cohort Studies; Female; Hepati | 2023 |
Primary cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Sjögren syndrome: A case report.
Topics: Amyloidosis, Familial; Anti-Inflammatory Agents; Azathioprine; Cholagogues and Choleretics; Drug The | 2018 |
Biliary features in liver histology of children with autoimmune liver disease.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cholangitis; Cholangitis, Sclerosing; Drug Therap | 2019 |
Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Crohn Disease; | 2013 |
Case-control study on prednisolone combined with ursodeoxycholic acid and azathioprine in pure primary biliary cirrhosis with high levels of immunoglobulin G and transaminases: efficacy and safety analysis.
Topics: Adult; Azathioprine; Case-Control Studies; Cholagogues and Choleretics; Drug Therapy, Combination; F | 2014 |
Management of autoimmune and cholestatic liver disorders.
Topics: Anti-Inflammatory Agents; Azathioprine; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Chol | 2009 |
De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report.
Topics: Azathioprine; Biopsy; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, Autoimmune; Hum | 2010 |
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases.
Topics: Adult; Antibodies, Antinuclear; Azathioprine; Biopsy; Enzyme-Linked Immunosorbent Assay; Female; Hep | 2011 |
[Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis].
Topics: Adult; Aged; Azathioprine; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive | 2012 |
Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate | 2013 |
[Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?].
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Dermatologic Ag | 2002 |
[Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cholagogues and Choleretics; Drug Therapy, Comb | 2003 |
[The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases].
Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Cholagogues and Choleretics; Clinical | 2003 |
Dichotomizing continuous predictors in multiple regression: a bad idea.
Topics: Age Factors; Albumins; Antimetabolites; Azathioprine; Bilirubin; Cholestasis; Data Interpretation, S | 2006 |
[Overlap syndrome autoimmune hepatitis and primary biliary cirrhosis associated with antiphospholipid syndrome].
Topics: Adult; Antibodies, Antinuclear; Antiphospholipid Syndrome; Arrhythmias, Cardiac; Autoantibodies; Aut | 2006 |
Guidelines for therapy of autoimmune liver disease.
Topics: Animals; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Glucocorticoids; Hepati | 2007 |
Development of autoimmune hepatitis in primary biliary cirrhosis.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Azathioprine; Ch | 2007 |
NIH conference: Primary biliary cirrhosis: a model autoimmune disease.
Topics: Antibody Formation; Autoimmune Diseases; Azathioprine; Bile Ducts, Intrahepatic; Cholestasis; Humans | 1983 |
[Therapy of primary biliary cirrhosis].
Topics: Antilymphocyte Serum; Azathioprine; Humans; Liver Cirrhosis, Biliary; Nitroglycerin; Penicillamine; | 1980 |
Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies?
Topics: Aged; Azathioprine; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Neoplasms; Retrospe | 1982 |
The effectivity of immunosuppressive therapy on chronic aggressive (active) hepatitis and on chronic nonsuppurative destructive cholangitis (PBC). Morphometric investigations on the portal tracts of the liver.
Topics: Azathioprine; Bile Ducts, Intrahepatic; Female; Hepatitis, Chronic; Humans; Immunotherapy; Liver; Li | 1982 |
Primary biliary cirrhosis and cold autoimmune hemolytic anemia: effect of partial plasma exchange.
Topics: Agglutinins; Anemia, Hemolytic, Autoimmune; Autoantibodies; Azathioprine; Cold Temperature; Erythroc | 1980 |
D-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis--successful treatment with plasmapheresis and immunosuppressives.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Azathioprine; Female; Humans; Liver Cirrhosis, Bil | 1980 |
Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarc | 1995 |
[Severe sicca syndrome associated with primary biliary cirrhosis. Value of an immunosuppressive treatment].
Topics: Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, | 1995 |
Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report.
Topics: Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Female; Hepatitis, Chronic; Humans; Im | 1994 |
Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis.
Topics: Adult; Aged; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Azathioprine; Biopsy; Cho | 1994 |
Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; Azathioprine; Cholangitis; Cyc | 1996 |
Bile acid therapy and markers of immune-mediated damage in primary biliary cirrhosis.
Topics: Anti-Inflammatory Agents; Azathioprine; Biomarkers; Cholagogues and Choleretics; Drug Therapy, Combi | 1997 |
Primary biliary cirrhosis treated with azathioprine and liver transplantation.
Topics: Azathioprine; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantat | 1997 |
Chronic actinic dermatitis associated with primary biliary cirrhosis.
Topics: Aged; Azathioprine; Chronic Disease; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Bili | 1997 |
Bronchiolitis obliterans organising pneumonia and primary biliary cirrhosis-like lung involvement in a patient with primary biliary cirrhosis.
Topics: Adrenal Cortex Hormones; Antimetabolites; Azathioprine; Biopsy, Needle; Bronchoalveolar Lavage; Cryp | 1998 |
Primary biliary cirrhosis associated with membranous glomerulonephritis.
Topics: Adult; Azathioprine; Biopsy; Cholagogues and Choleretics; Diagnosis, Differential; Dipyridamole; Dru | 1999 |
Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Fatal Outcome; Hear | 1999 |
Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Topics: Adolescent; Adult; Antibody Specificity; Aryl Hydrocarbon Hydroxylases; Autoantibodies; Autoantigens | 2002 |
Primary biliary cirrhosis (PBC).
Topics: Azathioprine; Chronic Disease; Diagnosis, Differential; Hepatitis; Humans; Liver Cirrhosis, Biliary; | 1979 |
[Current insights in the treatment of primary biliary cirrhosis].
Topics: Azathioprine; Copper; Humans; Liver Cirrhosis, Biliary; Osteomalacia; Penicillamine; Pruritus; Vitam | 1978 |
Serum squalene levels in hepatobiliary diseases.
Topics: Acute Disease; Adult; Azathioprine; Biliary Tract Diseases; Cholestasis; Cholesterol; Cholestyramine | 1978 |
Extrahepatic malignancy in chronic liver disease: report of six cases.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Chronic Disease; Cystadenocarcinoma; Female; Hepatitis | 1976 |
[Combined form of chronic aggressive hepatitis primary biliary cirrhosis].
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Azathioprine; Chronic Disease; Female; Hepatitis; | 1977 |
Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Azathioprine; Cholangitis; Chronic Disease; Drug Admin | 1976 |
[Therapy of the chronic destructive, non-purulent cholangitis (primary biliary cirrhosis)].
Topics: Azathioprine; Calcium; Cholangitis; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; | 1976 |
Chronic liver diseases: current therapeutic options.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Cholangitis, Sclerosing; Chronic Disease | 1989 |
Primary biliary cirrhosis presenting as idiopathic thrombocytopenic purpura with deterioration after splenectomy.
Topics: Aged; Azathioprine; Female; Humans; Liver; Liver Cirrhosis, Biliary; Purpura, Thrombocytopenic; Sple | 1989 |
[Clinical-dispensary finding of patients with primary biliary cirrhosis].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Bilirubin; Diagnosis, Differential; | 1985 |
[Are there new aspects in the therapy of primary biliary cirrhosis?].
Topics: Azathioprine; Bile Acids and Salts; Bilirubin; Cyclosporins; Humans; Liver Cirrhosis, Biliary; Liver | 1986 |
Treatment of chronic active hepatitis and other liver diseases with corticosteroid agents.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Hepatitis, Alcoholic; Hepatitis, Chronic | 1987 |
The effects of azathioprin in patients with cirrhosis of the liver.
Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Azathioprine; Bilirubin; Female; gamma-Glob | 1970 |
Total haemolytic complement after liver transplantation and in liver disease.
Topics: Acute Disease; Adult; Aspartate Aminotransferases; Azathioprine; Bilirubin; Carcinoma, Hepatocellula | 1972 |
Clinical use of corticosteroid and immunosuppressive drugs in liver disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Biliary Tract Diseases; Chemical and D | 1974 |
[Primitive biliary cirrhosis. Difficulties of an early diagnosis].
Topics: Adult; Aged; Autoantibodies; Azathioprine; Biopsy; Female; Humans; Liver; Liver Cirrhosis, Biliary; | 1974 |
Mitochondrial antibody in primary biliary cirrhosis and other diseases.
Topics: Antibodies; Azathioprine; Biliary Tract Diseases; Biopsy; Chemical and Drug Induced Liver Injury; Ch | 1972 |
Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine.
Topics: Adolescent; Adult; Animals; Azathioprine; Chronic Disease; Erythrocytes; Female; Hepatitis; Humans; | 1972 |
Chronic active liver disease: classification and treatment.
Topics: Aspartate Aminotransferases; Autoimmune Diseases; Azathioprine; Chronic Disease; Diagnosis, Differen | 1973 |
Primary biliary cirrhosis in twin sisters.
Topics: Adult; Azathioprine; Diseases in Twins; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunogl | 1973 |
[Immunosuppressive therapy of chronic aggressive hepatitis].
Topics: Adult; Azathioprine; Chronic Disease; Female; Glucocorticoids; Hepatitis; Humans; Immunosuppressive | 1973 |
Cell-mediated immune responses in chronic liver diseases.
Topics: Acidosis, Renal Tubular; Antigens; Autoimmune Diseases; Azathioprine; Cell Migration Inhibition; Chr | 1972 |
[Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
Topics: Adult; Aged; Alanine Transaminase; Alcoholism; Aspartate Aminotransferases; Azathioprine; Blood Cell | 1972 |
The case of a woman suffering from primary biliary cirrhosis for an unusually long time. Attempts at treatment, especially with azathioprine. Alkaline phosphatase activity during two pregnancies.
Topics: Adult; Alkaline Phosphatase; Azathioprine; Female; Humans; Liver Cirrhosis, Biliary; Pregnancy; Time | 1972 |
[Immunosuppressive treatment of chronic hepatitis].
Topics: Adolescent; Adult; Aged; Azathioprine; Blood Proteins; Chronic Disease; Depression, Chemical; Dexame | 1970 |
Natural history of active chronic hepatitis. II. Pathology, pathogenesis and clinico-pathological correlation.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Biliary Tract Disease | 1968 |